While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common variations have confounded doctors and left anxious patients without guidance ...

A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results ...

A recent study that focused on women under 55 years old found an increase in pancreatic cancer cases. Mercy Medical Center Dr ...

A recent study that focused on women under 55 years old found an increase in pancreatic cancer cases.Mercy Medical Center Dr.

Scientists at Children's Medical Research Institute have solved a big mystery in cancer research – why cells die in different ...

Preventative care can not only just save lives. Early intervention can also boost your employee health, productivity and ...

Allison Kurian and Jennifer Caswell-Jin will lead the PROACT program, a new breast and ovarian cancer initiative to improve ...

NICE's endorsement of olaparib, produced by AstraZeneca, marks a crucial step forward in the treatment of breast cancer. This ...

A groundbreaking study led by the Mayo Clinic Comprehensive Cancer Center has significantly deepened our understanding of ...

Scientists have taken a significant step in understanding mutations in the BRCA2 gene, associated with increased cancer risk, ...

"I just wish someone had told me this was a possibility." Kara Maxwell distinctly remembers the moment she heard those words ...

The institute originally began reviewing Lynparza in this setting in 2018 but ended its review due to lack of evidence.